These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6327962)

  • 21. [Use of cyproheptadine (Peritol) as a drug blocking corticotropin secretion in the treatment of Cushing's syndrome].
    Komissarenko IV; Cheban AK; Rybakov SI; Pomerantsev IuV; Slavnov VI
    Probl Endokrinol (Mosk); 1981; 27(6):39-42. PubMed ID: 6275378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dynamics of beta-lipotropin and beta-endorphin levels in Itsenko-Cushing disease patients being treated with the antiserotonin preparation cyproheptadine (peritol) and chloditan].
    Slavnov VN; Valueva GV; Luchitskiĭ EV
    Ter Arkh; 1984; 56(9):119-22. PubMed ID: 6096979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on drug therapy of Cushing's syndrome].
    Winkelmann W; Fricke U; Hackenberg K; Heesen D; Hoff HG; Hummerich W; Liesen H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1337-40. PubMed ID: 347777
    [No Abstract]   [Full Text] [Related]  

  • 24. [Criteria for the selection of drugs for the pathogenetic treatment of Itsenko-Cushing disease].
    Slavnov VN; Luchitskiĭ EV; Cheban AK
    Ter Arkh; 1985; 57(12):36-9. PubMed ID: 3003946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct effects of thyrotropin-releasing hormone, cyproheptadine, and dopamine on adrenocorticotropin secretion from human corticotroph adenoma cells in vitro.
    Ishibashi M; Yamaji T
    J Clin Invest; 1981 Oct; 68(4):1018-27. PubMed ID: 6270192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes in the secretion of the hormones of the hypothalamo-hypophyseo-adrenal system in Itsenko-Cushing disease under the influence of insulin-induced hypoglycemia and thyroliberin].
    Slavnov VN; Luchitskiĭ EV
    Vrach Delo; 1990 Mar; (3):72-5. PubMed ID: 2164280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Potential use of the antiserotonin preparation cyproheptadine (peritol) in Itsenko-Cushing disease].
    Valueva GV; Luchitskiĭ EV; Iakovlev AA
    Farmakol Toksikol; 1983; 46(2):50-3. PubMed ID: 6852218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained remission of Nelson's syndrome after stopping cyproheptadine treatment.
    Aronin N; Krieger DT
    N Engl J Med; 1980 Feb; 302(8):453-5. PubMed ID: 6243392
    [No Abstract]   [Full Text] [Related]  

  • 29. Editorial: Cushing's disease: a hypothalamic flush?
    Feldman JM
    N Engl J Med; 1975 Oct; 293(18):930-1. PubMed ID: 170520
    [No Abstract]   [Full Text] [Related]  

  • 30. Cushing's disease: failure of treatment with cyproheptadine.
    Allgrove J; Husband P; Brook CG
    Br Med J; 1977 Mar; 1(6062):686-7. PubMed ID: 843872
    [No Abstract]   [Full Text] [Related]  

  • 31. Cyproheptadine for Cushing's disease (cont.).
    Scott R; Espiner EA; Donald RA
    N Engl J Med; 1977 Jan; 296(1):57-8. PubMed ID: 830282
    [No Abstract]   [Full Text] [Related]  

  • 32. More on cyproheptadine.
    Tyrrell JB; Brooks RM; Forsham PH
    N Engl J Med; 1976 Nov; 295(20):1137-8. PubMed ID: 980014
    [No Abstract]   [Full Text] [Related]  

  • 33. Rebound elevation of cortisol following cyproheptadine withdrawal in Cushing's disease from a pituitary macroadenoma.
    Ooi TC; Twum-Barima Y
    J Endocrinol Invest; 1987 Apr; 10(2):107-9. PubMed ID: 3584851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyproheptadine and Cushing's disease.
    Burrows AW; Burke CW; Rees LH
    Br Med J; 1977 Apr; 1(6068):1084. PubMed ID: 858057
    [No Abstract]   [Full Text] [Related]  

  • 35. Cyproheptadine in Cushing's syndrome.
    Marek J; Matys Z; Gregorová I
    Lancet; 1977 Sep; 2(8039):653-4. PubMed ID: 71464
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of Cushing's disease with cyproheptadine (author's transl)].
    Terayama Y; Furusawa M; Hitomi H; Morita S; Futagawara K
    Horumon To Rinsho; 1981 Jul; 29(7):831-5. PubMed ID: 7307300
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug treatment of Cushing's syndrome with cyproheptadine].
    Seyer-Hansen K; Weeke J; Møller J
    Ugeskr Laeger; 1979 Sep; 141(37):2518-20. PubMed ID: 483437
    [No Abstract]   [Full Text] [Related]  

  • 38. [Preliminary results of treatment of Cushing's syndrome with cyproheptadine].
    Hartwig W; Kasperlik-Załuska A; Migdalska B; Wilczyńska J; Wiśniewska-Woźniak T; Załuska J
    Endokrynol Pol; 1979; 30(2):163-70. PubMed ID: 467383
    [No Abstract]   [Full Text] [Related]  

  • 39. Cyproheptadine treatment in Cushing's disease.
    Tanakol R; Alagöl F; Azizlerli H; Sandalci O; Terzioğlu T; Berker F
    J Endocrinol Invest; 1996 Apr; 19(4):242-7. PubMed ID: 8862505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment with cyproheptadine of a recurrent case of Cushing's disease].
    González LR; Gándara JR
    Bol Asoc Med P R; 1976 Oct; 68(10):264-6. PubMed ID: 791301
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.